FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2928930162> ?p ?o ?g. }

• W2928930162 endingPage "936" @default.
• W2928930162 startingPage "925" @default.
• W2928930162 abstract "The cannabinoid receptor 2 (CB2) plays a pleiotropic role in the innate immunity and is considered a crucial mediator of liver disease. Cannabinoid CB2 receptor activation has been reported to attenuate liver fibrosis in CCl4 exposed mice and also plays a potential role in liver regeneration in a mouse model of I/R and protection against alcohol-induced liver injury.In this study, we investigated the impact of CB2 receptors on the antifibrotic and regenerative process associated with cholestatic liver injury.Twenty-six rats had bile duct ligation co-treated with silymarin and AM1241 for 3 consecutive weeks. Serum hepatotoxicity markers were determined, and histopathological evaluation was performed.Following bile duct ligation (BDL) for 3 weeks, there was increased aminotransferase levels, marked inflammatory infiltration and hepatocyte apoptosis with induced oxidative stress, as reflected by increased lipid peroxidation. Conversely, following treatment with the CB2 agonist, AM-1241, BDL rats displayed a reduction in liver injury and attenuation of fibrosis as reflected by expression of hydroxyproline and α-smooth muscle actin. AM1241 treatment also significantly attenuated lipid peroxidation end-products, p53-dependent apoptosis and also attenuated inflammatory process by stimulating IL-10 production. Moreover, AM1241 treated rats were associated with significant expression of hepatic progenitor/oval cell markers.In conclusion, this study points out that CB2 receptors reduce liver injury and promote liver regeneration via distinct mechanisms including IL-10 dependent inhibition of inflammation, reduction of p53-reliant apoptosis and through stimulation of oval/progenitor cells. These results suggest that CB2 agonists display potent hepatoregenrative properties, in addition to their antifibrogenic effects." @default.
• W2928930162 created "2019-04-11" @default.
• W2928930162 creator A5022031981 @default.
• W2928930162 creator A5050001828 @default.
• W2928930162 creator A5061640525 @default.
• W2928930162 creator A5084611563 @default.
• W2928930162 creator A5087279532 @default.
• W2928930162 date "2019-03-29" @default.
• W2928930162 modified "2023-10-03" @default.
• W2928930162 title "AM-1241 CB2 Receptor Agonist Attenuates Inflammation, Apoptosis and Stimulate Progenitor Cells in Bile Duct Ligated Rats" @default.
• W2928930162 cites W103744737 @default.
• W2928930162 cites W1195173312 @default.
• W2928930162 cites W1539472260 @default.
• W2928930162 cites W1593555249 @default.
• W2928930162 cites W1603929148 @default.
• W2928930162 cites W176224146 @default.
• W2928930162 cites W1870790255 @default.
• W2928930162 cites W1964948984 @default.
• W2928930162 cites W1969904298 @default.
• W2928930162 cites W1976772672 @default.
• W2928930162 cites W1981661202 @default.
• W2928930162 cites W1985196803 @default.
• W2928930162 cites W1987282 @default.
• W2928930162 cites W1990856438 @default.
• W2928930162 cites W1996535499 @default.
• W2928930162 cites W2007456787 @default.
• W2928930162 cites W2011202576 @default.
• W2928930162 cites W2014142239 @default.
• W2928930162 cites W2027688921 @default.
• W2928930162 cites W2031222013 @default.
• W2928930162 cites W2034016494 @default.
• W2928930162 cites W2036096793 @default.
• W2928930162 cites W2048805706 @default.
• W2928930162 cites W2054556504 @default.
• W2928930162 cites W2059749815 @default.
• W2928930162 cites W2062754425 @default.
• W2928930162 cites W2074561249 @default.
• W2928930162 cites W2074966179 @default.
• W2928930162 cites W2078775914 @default.
• W2928930162 cites W2083415995 @default.
• W2928930162 cites W2096748864 @default.
• W2928930162 cites W2106174458 @default.
• W2928930162 cites W2107278522 @default.
• W2928930162 cites W2126100180 @default.
• W2928930162 cites W2129418287 @default.
• W2928930162 cites W2130768392 @default.
• W2928930162 cites W2133052414 @default.
• W2928930162 cites W2135530906 @default.
• W2928930162 cites W2141269207 @default.
• W2928930162 cites W2143425403 @default.
• W2928930162 cites W2154278853 @default.
• W2928930162 cites W2158129157 @default.
• W2928930162 cites W2162507709 @default.
• W2928930162 cites W2163346237 @default.
• W2928930162 cites W2164047272 @default.
• W2928930162 cites W2170281217 @default.
• W2928930162 cites W2171583239 @default.
• W2928930162 cites W2184839737 @default.
• W2928930162 cites W2263023695 @default.
• W2928930162 cites W2318436667 @default.
• W2928930162 cites W2345654927 @default.
• W2928930162 cites W2468118389 @default.
• W2928930162 cites W2469893244 @default.
• W2928930162 cites W2506510287 @default.
• W2928930162 cites W2533055041 @default.
• W2928930162 cites W2580365663 @default.
• W2928930162 cites W2730973121 @default.
• W2928930162 cites W2756343284 @default.
• W2928930162 cites W2785758228 @default.
• W2928930162 cites W2792709052 @default.
• W2928930162 doi "https://doi.org/10.3889/oamjms.2019.194" @default.
• W2928930162 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6454175" @default.
• W2928930162 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30976335" @default.
• W2928930162 hasPublicationYear "2019" @default.
• W2928930162 type Work @default.
• W2928930162 sameAs 2928930162 @default.
• W2928930162 citedByCount "4" @default.
• W2928930162 countsByYear W29289301622021 @default.
• W2928930162 countsByYear W29289301622023 @default.
• W2928930162 crossrefType "journal-article" @default.
• W2928930162 hasAuthorship W2928930162A5022031981 @default.
• W2928930162 hasAuthorship W2928930162A5050001828 @default.
• W2928930162 hasAuthorship W2928930162A5061640525 @default.
• W2928930162 hasAuthorship W2928930162A5084611563 @default.
• W2928930162 hasAuthorship W2928930162A5087279532 @default.
• W2928930162 hasBestOaLocation W29289301621 @default.
• W2928930162 hasConcept C126322002 @default.
• W2928930162 hasConcept C134018914 @default.
• W2928930162 hasConcept C170493617 @default.
• W2928930162 hasConcept C201750760 @default.
• W2928930162 hasConcept C2776637226 @default.
• W2928930162 hasConcept C2776914184 @default.
• W2928930162 hasConcept C2778938600 @default.
• W2928930162 hasConcept C2780559512 @default.
• W2928930162 hasConcept C28328180 @default.
• W2928930162 hasConcept C71924100 @default.
• W2928930162 hasConcept C86803240 @default.
• W2928930162 hasConcept C95444343 @default.

• next